1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Europe Liquid Biopsy Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Europe Liquid Biopsy Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1
- 5.1.2 Rising preference for miimally invasive cancer diagnostics
5.2 Market Opportunities
- 5.2.1 Increasing liquid biopsy driven by growing application and advancements
5.3 Future Trends
- 5.3.1
- 5.3.2 Advancements in detection technologies
- 5.3.3 expanding clinical applications
- 5.3.4 Global market expansion
5.4 Impact of Drivers and Restraints
6. Europe Liquid Biopsy Market Regional Analysis
6.1 Europe Liquid Biopsy Market Overview
6.2 Europe Liquid Biopsy Market Revenue 2016-2027 (US$ Million)
6.3 Europe Liquid Biopsy Market Forecast Analysis
7. Europe Liquid Biopsy Market Analysis – by Product & Services
7.1 Equipment
- 7.1.1 Overview
- 7.1.2 Equipment: Europe Liquid Biopsy Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Reagents & Kits and Services
- 7.2.1 Overview
- 7.2.2 Reagents & Kits and Services: Europe Liquid Biopsy Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Liquid Biopsy Market Analysis – by Sample
8.1 Blood Based
- 8.1.1 Overview
- 8.1.2 Blood Based: Europe Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Urine Based and Other samples
- 8.2.1 Overview
- 8.2.2 Urine Based and Other samples: Europe Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)
9. Europe Liquid Biopsy Market Analysis – by Circulating Biomarker
9.1 Circulating Tumor Cells
- 9.1.1 Overview
- 9.1.2 Urine Based and Other samples: Europe Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)
9.2 Exosomes and Free Nucleic Acid
- 9.2.1 Overview
- 9.2.2 Urine Based and Other samples: Europe Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)
10. Europe Liquid Biopsy Market – Europe Analysis
10.1 Europe
- 10.1.1 Europe Liquid Biopsy Market Breakdown, by Key
Country, 2019 and 2027 (%)
- 10.1.1.1 Europe Liquid Biopsy Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 UK:
Europe Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.1.1 UK: Europe Liquid Biopsy Market Breakdown, by Product & Services
- 10.1.1.1.2 UK: Europe Liquid Biopsy Market Breakdown, by Sample
- 10.1.1.1.3 UK: Europe Liquid Biopsy Market Breakdown, by Circulating Biomarker
- 10.1.1.2 Germany:
Europe Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.2.1 Germany: Europe Liquid Biopsy Market Breakdown, by Product & Services
- 10.1.1.2.2 Germany: Europe Liquid Biopsy Market Breakdown, by Sample
- 10.1.1.2.3 Germany: Europe Liquid Biopsy Market Breakdown, by Circulating Biomarker
- 10.1.1.3 France:
Europe Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.3.1 France: Europe Liquid Biopsy Market Breakdown, by Product & Services
- 10.1.1.3.2 France: Europe Liquid Biopsy Market Breakdown, by Sample
- 10.1.1.3.3 France: Europe Liquid Biopsy Market Breakdown, by Circulating Biomarker
- 10.1.1.4 Russia:
Europe Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.4.1 Russia: Europe Liquid Biopsy Market Breakdown, by Product & Services
- 10.1.1.4.2 Russia: Europe Liquid Biopsy Market Breakdown, by Sample
- 10.1.1.4.3 Russia: Europe Liquid Biopsy Market Breakdown, by Circulating Biomarker
- 10.1.1.5 Italy:
Europe Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.5.1 Italy: Europe Liquid Biopsy Market Breakdown, by Product & Services
- 10.1.1.5.2 Italy: Europe Liquid Biopsy Market Breakdown, by Sample
- 10.1.1.5.3 Italy: Europe Liquid Biopsy Market Breakdown, by Circulating Biomarker
- 10.1.1.6 Rest of Europe:
Europe Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.6.1 Rest of Europe: Europe Liquid Biopsy Market Breakdown, by Product & Services
- 10.1.1.6.2 Rest of Europe: Europe Liquid Biopsy Market Breakdown, by Sample
- 10.1.1.6.3 Rest of Europe: Europe Liquid Biopsy Market Breakdown, by Circulating Biomarker
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Europe Liquid Biopsy Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 F. Hoffmann-la Roche ltd
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Inivata Ltd
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 LungLife AI, Inc.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Exosome Diagnostics
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 MDxHealth
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
14. Appendix
14.1 About Business Market Insights
Get Free Sample For Europe Liquid Biopsy Market
